I. Audo FRANCE

14:45 Welcome

N. Paudel IRELAND

14:47 Genetic testing experiences of people living with inherited retinal diseases (IRDs) – results of a global survey

I. Audo FRANCE

14:53 RLIGHT – Observational study on the use of voretigene neparvovec (VN) in patients with inherited retinal dystrophy (IRD) at CHNO des Quinze-Vingts: a 1-year follow-up safety and efficacy results

D. Fischer UK

14:59 Real-world safety and effectiveness of voretigene neparvovec: Year 2 interim results from the PERCEIVE study

V. Gonzalez USA

15:05 Development of Novel Endpoints for the Study of Multi-Characteristic Opsin Enabled Vision Restoration in Patients with Advanced Retinitis Pigmentosa; Double-masked, Randomized, sham-controlled, Multicenter Phase 2b study

J. Wawrzynski UK

15:11 Intravitreal Cerliponase alfa for the treatment of Neuronal Ceroid Lipofuscinosis type 2 (CLN2) related retinal dystrophy: A first in man report of ocular enzyme replacement.

S.N Geada Batista PORTUGAL

15:17 Expanding the mutational spectrum of CNGB1-associated RP-olfactory dysfunction syndrome

L. Mautone GERMANY

15:23 Diurnal changes of macular anatomy and sensitivity in X-linked juvenile retinoschisis

H. Baran Özdemir TURKEY

15:29 Congenital X-Linked Retinoschisis: Surgical Needs and Outcomes in Long Term. A Retrospective Multicenter International Study

M. Mateos SPAIN

15:35 Hair cortisol level as a molecular biomarker in retinitis pigmentosa patients

All Faculty

15:41 Discussion